Overview

A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the healing rate and safety of Lafutidine in erosive esophagitis
Phase:
Phase 3
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Treatments:
Famotidine
Lafutidine
Omeprazole